TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
BNR

Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

18.90$ +7.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Burning Rock Biotech Ltd (BNR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million CNY. Tick rows to compare them in a chart.

All figures in millions of CNY.

Tick rows to compare them in a chart (up to 4)

Cash Flow BNR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-134 -149 -228 -74 -478 -457 -256 -92 -28
21 25 31 33 48 124 133 52 22
4.1 5.1 23 173 282 327 261 156 14
11 10 40 188 319 401 – – –
-35 -6.2 -130 112 -62 -11 -52 -37 -59
23 25 46 80 213 62 9.4 6.0 5.2
-191 106 -347 -109 82 -7.5 -9.3 -4.4 -4.4
– – – 360 – – – – –
-9.1 -1.5 -3.6 -3.5 -4.3 -72 -7.0 -0.1 0.0
129 83 -82 -21 -45 -2.4 0.0 0.0 1.9
354 83 572 2,166 -53 -86 -49 -0.1 1.9
18 41 2.9 1,827 -486 -514 -310 -93 -41
-157 -173 -274 -153 -691 -519 -265 -98 -34

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?